Results 181 to 190 of about 1,286,748 (345)

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung, Desmond Y. H. Yap, Ka Lai Lee, Philip H. Li, Iris Y. K. Tang, Chak Sing Lau, Shirley C. W. Chan   +6 more
wiley   +1 more source

Energy performance of MRI systems: on-site validation and comparison with manufacturer declarations. [PDF]

Eur Radiol Exp
Roletto A, Verga M, Savio A, Viganò GL, Zanoni S.   +4 more
europepmc   +1 more source

Performance improvement of a diesel generating set with fuzzy control for stand-alone and grid-connected operations. [PDF]

This paper proposes a management strategy for\ud a diesel generating set (GS) covering the mechanical part of\ud the system which includes speed and active power control,\ud the electrical part of the system which includes voltage\ud and reactive power ...
Aguiar, Cassius Rossi de, Bastos, Renan Fernandes, Machado, Ricardo Quadros, Neves, Rodolpho Vilela Alves, Oliveira, Vilma Alves de, Reis, Giann Braune   +5 more
core  

Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial

Arthritis Care &Research, EarlyView.
Objective Although treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL ...
Austin Barry, Bryant R. England, Harlan Sayles, Lindsay N. Helget, Maria Androsenko, Hongsheng Wu, Kaleb Michaud, Bridget Kramer, Jeff A. Newcomb, Mary T. Brophy, Anne Davis‐Karim, Ryan Ferguson, Michael H. Pillinger, Tuhina Neogi, Paul M. Palevsky, James R. O'Dell, Ted R. Mikuls   +16 more
wiley   +1 more source

Asynchronous Stepped Fourier Transform Ion Mobility Spectrometry. [PDF]

J Am Soc Mass Spectrom
Edstrom E, Gharari S, Davis E.
europepmc   +1 more source

Stand-alone wind power system operating with a specific storage structure

, 2009
M. Druga, Cristian Nichita, Georges Barakat, E. Ceangă   +3 more
openalex   +1 more source

Long‐Term Opioids in Gout: A Matched Cohort Study From the Veterans Health Administration

Arthritis Care &Research, EarlyView.
Objective Though used frequently to treat flare, risk of long‐term opioid exposure in gout has not been well defined. In this study, we examined the hypothesis that people with gout are more likely than individuals without gout to be prescribed long‐term opioids over time.
Lindsay N. Helget, Bryant R. England, Punyasha Roul, Harlan Sayles, Tuhina Neogi, James R. O'Dell, Joshua F. Baker, Ted R. Mikuls   +7 more
wiley   +1 more source

Robust direct voltage control of stand-alone DFIG wind systems using a fractional-order fuzzy logic approach. [PDF]

Sci Rep
Boucetta F, Alturki M, Albaker A, Alqunun K, Benchouia MT, Alshammari BM, Becherif M, Guesmi T.   +7 more
europepmc   +1 more source

Load control of a wind-hydrogen stand-alone power system

, 2005
Harald Miland, Ronny Glöckner, Peter J. Taylor, R JARLEAABERG, G. Hägen   +4 more
openalex   +2 more sources

Cost‐Effectiveness of Low‐Dose Colchicine Prophylaxis When Starting Allopurinol Using the “Start‐Low Go‐Slow” Approach for Gout: Evidence From a Noninferiority Randomized Double‐Blind Placebo‐Controlled Trial

Arthritis Care &Research, EarlyView.
Objective The aim of this study was to investigate the cost‐effectiveness of low‐dose colchicine prophylaxis for preventing gout flares when starting allopurinol using the “start‐low go‐slow” approach. Methods Participants with gout, fulfilling the American College of Rheumatology recommendations for starting urate‐lowering therapy and with serum urate
Yana Pryymachenko, Ross Wilson, Nicola Dalbeth, J. Haxby Abbott, Lisa Stamp   +4 more
wiley   +1 more source